Lisinopril and Hydrochlorothiazide
- Product NDC
- 71610-374
- 11-digit product format
- 716100374
- Labeler code
- 71610
- Product ID
- 71610-374_29eb83f5-d92a-4b6f-acf6-3deecf7c4f9f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide Tablets
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA204058
- Marketing category
- ANDA
- Marketing start
- 2019-05-01
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Active strength
- 12.5; 20 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 0J48LPH2TH | HYDROCHLOROTHIAZIDE | 58-93-5 | HYDROCHLOROTHIAZIDE |
| E7199S1YWR | LISINOPRIL | 83915-83-7 | LISINOPRIL |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71610-374-60 | 71610037460 | 90 TABLET in 1 BOTTLE (71610-374-60) | 90 tablet | 2020-01-13 | No | No | Historical |
| 71610-374-80 | 71610037480 | 180 TABLET in 1 BOTTLE (71610-374-80) | 180 tablet | 2019-12-16 | No | No | Historical |